Scleral Lens Market to Hit US$ 321.4 Million by 2031 | Exclusive Report by Growth Plus Reports

 | Source: Growth Plus Reports Growth Plus Reports

Newark, New Castle, USA, June 12, 2023 (GLOBE NEWSWIRE) -- A recent report by Growth Plus Reports estimated the global scleral lens market to be worth US$ 220.0 million in 2022. From 2023 to 2031, market revenue is expected to grow at a CAGR of 4.3%, reaching US$ 321.4 million. The most successful strategies, market trends, the competitive environment, significant drivers and opportunities, statistical data, market size, and revenue are all included in the report. 

Key Takeaways: 

  • The rising prevalence of ocular disorders is driving the market revenue growth. 
  • The rising demand for the scleral lens over conventional lenses also accelerates the revenue share. 
  • Significant R&D investments are creating a strong product pipeline. 

Request a Free Sample of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/scleral-lens-market/8491

                                                       
                                                        Scleral Lens Market Scope

Report AttributeDetails
Market size value in 2022US$ 220.0 million
Revenue forecast in 2031US$ 321.4 million
Growth RateCAGR of 4.3% from 2023 to 2031
Base Year for Estimation2022
Forecast Period2023-2031
Historical Year2021
Segments CoveredType, Application, End User, and Region.
Regional ScopeNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa


Market Drivers: 
With the rising prevalence of myopia, irregular cornea, ocular surface disease, refractive error, hyperopia, astigmatism, and presbyopia, the global market revenue for the scleral lens is growing. Furthermore, the advantages of scleral lenses over conventional contact lenses, such as their exceptional comfort and visual correction, are accelerating the market revenue growth.  

Market Segmentation: 
Growth plus reports have analyzed the global scleral lens market from perspectives such as type, application, end-user, and region. 

Type Segmentation: 
Based on type, the global scleral lens market is segmented into mini-scleral lenses and large scleral lenses.

The mini scleral lenses segment accounts for the largest market revenue share due to the prevalence of keratoconus, dry eye syndrome, and other ocular diseases, driving the demand for the formation of technologically advanced lenses. 

Application Segmentation: 
Based on application, the global scleral lens market has been segmented into ocular surface disease, irregular cornea, refractive error, and others. 

The ocular surface disease segment accounts for the largest market revenue share due to the prevalence of dry eye disease resulting in irreversible vision loss. 

Request for Customization – https://www.growthplusreports.com/inquiry/customization/scleral-lens-market/8491

End-User Segmentation: 

Based on end-user, the global scleral lens market has been segmented Into hospitals, eye clinics, and others.

The eye clinics segment accounts for the largest market revenue share due to the rise in private practitioners, profitable income, and processes for lens fitting in eye clinics. In addition, market participants focus on distributing their products through eyecare professionals, the growing accessibility and awareness of scleral products due to local reach, and the patient-tailored strategy used by eye clinics are all expected to support the segment's revenue growth during the forecast period. 

Regional Growth Dynamics: 
Based on region, the global scleral lens market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

North America accounts for the largest global scleral lenses market revenue share due to the rising number of eye injuries and disorders, key players' growing R&D activity, alliances, and unique product releases. 

Competitive Landscape:
The prominent players operating in the global scleral lens market are: -

  • Bausch Health Companies Inc.
  • ABB Optical Group
  • Art Optical Contact Lens, Inc.
  • CooperVision, Inc.
  • EssilorLuxotica
  • SynergEyes
  • AccuLens Inc.
  • Menicon Co., Ltd.
  • Tru-Form Optics
  • BostonSight SCLERAL

New product releases and higher R&D spending are two main techniques used by significant players to get a larger market share. Both domestic and international companies that manufacture scleral lenses are concentrating on launching unique products while expanding their R&D efforts and monitoring the entry of new competitors. 

Recent Developments: 

  • In November 2021, CooperVision Specialty EyeCare offered Optimized Pupil Optics (OPO) to eye care professionals (ECPs) in the United States and Canada for its Onefit MED and Onefit MED+ scleral contact lenses.
  • In October 2021, the 28mm New Lens Bausch Health Companies Inc. released Zenlens Dx to meet the rising demand for gas-permeable lenses to cure vision problems brought on by irregularities in the cornea.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
    4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022)
    3. Regulatory Landscape
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3.  Opportunities
    4. Regulatory Scenario
  5. GLOBAL SCLERAL LENS MARKET - ANALYSIS & FORECAST, BY TYPE
    1. Mini-Scleral Lenses
    2. Large Scleral Lenses
  6. GLOBAL SCLERAL LENS MARKET - ANALYSIS & FORECAST, BY APPLICATION
    1. Ocular Surface Disease
    2. Irregular Cornea
    3. Refractive Error
    4. Others
  7. GLOBAL SCLERAL LENS MARKET - ANALYSIS & FORECAST, BY END USER
    1. Hospitals
    2. Eye Clinics
    3. Others

SCLERAL LENS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8491

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at - https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Combination Hypertension Agents Market by Drug Class (β Blockers and Diuretics, Angiotensin-converting-enzyme Inhibitors, and Diuretics, Angiotensin-converting-enzyme), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) - Global Outlook and Forecast 2023-2031

Catecholamine Market by Drug Type (Synthetic and Endogenous), Indication (Cardiac Arrest, Hypertension, Anaphylaxis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Oral Antianginal Agents Market by Drug Class (β-blockers, Calcium Channel Blockers), Distribution Channel (Hospital Pharmacies, Online Pharmacies) – Global Outlook & Forecast 2023-2031

Veterinary High Frequency Diathermy Market by Product Type (Monopolar Diathermy Devices, Bipolar Diathermy Devices), Animal Type (Large Animals and Small Animals), Application (General Surgery, Ophthalmology, Orthopedics), End User (Veterinary Hospitals, Veterinary Clinics) - Global Outlook & Forecast 2023-2031

Anti-VEGF Therapeutics Market by Product (Lucentis, Eylea, and Beovu), Indications (Macular Edema, Retinal Vein Occlusion, and Diabetic Retinopathy) - Global Outlook and Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020".

 

            








        

            

                

                    
Mot-clé

                            
                                Scleral Lens Market
                            
                            
                                Scleral Lens Market Trends
                            
                            
                                Scleral Lens Market Outlook
                            
                            
                                Scleral Lens Market Share
                            

                



        


    

        
Hyperliens

        
    



    

        

        
Coordonnées